Medicine and new technology
Our Work

Latham Advises Health Catalyst in Secured Growth Financing

July 19, 2024
Firm represented the leading provider of healthcare data technology in a new growth financing.

Health Catalyst, Inc. (Nasdaq: HCAT) (Health Catalyst), a leading provider of data and analytics technology and services to healthcare organizations, has announced that it has entered into a new credit facility provided by Silver Point Finance, the direct lending business of Silver Point Capital, L.P. The new credit facility provides up to US$225 million in committed capital which consists of (i) an initial term loan facility in an aggregate principal amount of US$125 million and (ii) a delayed draw term loan facility in an aggregate principal amount of US$100 million.

Latham & Watkins LLP advised Health Catalyst in the transaction with a deal team led by transactional partners Jennifer Kent and Haim Zaltzman, with associates Hyunji Lee, Samantha Kosarzycki, and Lindsay Kenney. Advice was also provided on certain corporate matters by partners Rick Kline, Erica Kassman, Christopher Clark, Reza Mojtabaee-Zamani, and Greg Rodgers, with associates Shawn Noh, Julian Brody, and Kayleigh Kuyon; on tax matters by partner Grace Lee, with associate Dennis Poehland; on intellectual property matters by partner Michelle Gross, with associate Andrew Abokhair; on healthcare regulatory matters by partner Betty Pang, with counsel Chad Jennings; on data privacy matters by partner Heather Deixler, with associate Mitch Bennett; on ERISA matters by counsel Aryeh Zuber; on real estate matters by partner Dara Denberg; on UK matters by associate Corrie Eames; and on certain other regulatory matters by partner Joseph Bargnesi, counsel Joel Cavanaugh, with associate Eric Green.

Endnotes